FDA approves Lymphoseek for lymph node mapping

03/13/2013 | Medscape (free registration)

The FDA has approved Navidea Biopharmaceuticals' radioactive tracer Lymphoseek for breast cancer and melanoma intraoperative lymphatic mapping. The FDA said the tracer is the first agent for lymph node mapping to gain approval in more than three decades. "Removal and pathologic examination of lymph nodes draining a primary tumor is an important diagnostic evaluation for some patients with breast cancer or melanoma," said Dr. Shaw Chen of the FDA Center for Drug Evaluation and Research.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Litigation
Center for Science in the Public Interest
Washington, DC